Group 1 - The company Jiangsu Lixing General Steel Ball Co., Ltd. announced that three executives plan to reduce their shareholdings, with a total maximum reduction of 2,180,000 shares, accounting for 0.74% of the company's total share capital [1][2] - Executive Zhao Gaoming plans to reduce his holdings by up to 880,000 shares, representing 0.30% of the total share capital [1] - Executives Tang Guohua and Sha Xiaojian each plan to reduce their holdings by up to 650,000 shares, each representing 0.22% of the total share capital [1] Group 2 - As of the announcement date, Zhao Gaoming holds 3,566,275 shares (1.21%), Tang Guohua holds 2,639,284 shares (0.90%), and Sha Xiaojian holds 2,639,284 shares (0.90%), totaling 8,844,843 shares (3.01%) [1] - The reduction plan will be executed within three months after a 15-trading-day period following the announcement, adhering to relevant regulations regarding insider trading and stock sales by executives [2] - The company assures that the implementation of this reduction plan will not lead to a change in control or affect the governance structure and ongoing operations of the company [2]

Summary of Key Points - The company Lixing Co., Ltd. (300421) announced that its board member, deputy general manager, and chief engineer Zhao Gaoming plans to reduce his holdings by no more than 880,000 shares, which accounts for 0.30% of the company's total share capital [1] - Additionally, board member and deputy general manager Tang Guohua intends to reduce his holdings by no more than 650,000 shares, representing 0.22% of the total share capital [1] - Assistant general manager Sha Xiaojian also plans to reduce his holdings by no more than 650,000 shares, which is 0.22% of the total share capital [1] - The method of reduction will be through centralized bidding transactions, with the period set from July 9, 2025, to October 8, 2025 [1] - The reason for the reduction in holdings is stated as personal financial needs [1]

Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]

证券代码：300421 证券简称：力星股份 公告编号：2025-019 江苏力星通用钢球股份有限公司 关于取得企业境外投资证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 江苏力星通用钢球股份有限公司（以下简称"公司"）根据公司经营发展及战 略规划，经董事长审批通过，公司在新加坡设立了全资子公司江苏力星（新加坡） 私人有限公司（英文名：JGBR（SINGAPORE）PTE.LTD.），内容详见公司 2025 年 3 月 14 日在中国证监会指定创业板信息披露网站上刊登的《关于投资设立新 加坡全资子公司的公告》。 近日公司取得江苏省商务厅颁发的《企业境外投资证书》。现就相关情况公 告如下： 1、境外企业名称：江苏力星（新加坡）私人有限公司 2、国家/地区：新加坡 3、设立方式：新设 4、投资主体：江苏力星通用钢球股份有限公司，股比：100% 5、投资总额：216 万人民币（折合 30 万美元） 6、经营范围：机械设备及配件销售贸易、机械设备的安装及维护。 7、核准或备案文号：苏境外投资【2025】N00772 号 特此公告。 江苏力星通用钢球股份有限公 ...

Group 1 - Lixing Co., Ltd. has experienced a continuous decline in stock price for six consecutive trading days, with a cumulative drop of -8.96% [1] - Lixing Co., Ltd. specializes in the production and sales of high-precision bearing rolling elements and is recognized as a national high-tech enterprise, established in 1989 and listed on the Shenzhen Stock Exchange in 2015 [1] - The fund manager of Guoshou Anbao Smart Life Stock A, Zhang Qi, has increased holdings in Lixing Co., Ltd. during the first quarter of this year, with a year-to-date return of 4.07%, ranking 378 out of 979 in its category [1][3] Group 2 - The stock performance of Lixing Co., Ltd. shows a near-term decline of -2.06% over the past week and a year-to-date increase of 4.07%, compared to the average performance of its peers [2] - The company’s stock has seen a -10.15% decline over the past three months, while the Shanghai and Shenzhen 300 index has decreased by -2.52% in the same period [2] - Guoshou Anbao Fund Management Co., Ltd. was established in October 2013, with China Life Asset Management Co., Ltd. holding 85.03% of the shares [4]

力星股份（300421）公告，持本公司股份355.43万股的董事、副总经理王嵘计划自公告披露之日起15个 交易日后的3个月内，通过集中竞价交易方式减持不超过85万股，占公司总股本比例0.29%。 ...

江苏力星通用钢球股份有限公司 关于董事、高级管理人员减持股份预披露的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1、持本公司股份3,554,274股（占本公司总股本比例1.21%）的董事、副总经 理王嵘先生计划自本公告披露之日起15个交易日后的3个月内通过集中竞价交易 方式减持公司股份不超过850,000股，占公司总股本比例0.29%。 2、持本公司股份2,639,284股（占本公司总股本比例0.90%）的总经理助理、 董事会秘书陈芳女士计划自本公告披露之日起15个交易日后的3个月内通过集中 竞价交易方式减持公司股份不超过400,000股，占公司总股本比例0.22%。 3、持本公司股份2,637,911 股（占本公司总股本比例0.90%）的总经理助理 苏银建先生计划自本公告披露之日起15个交易日后的3个月内通过集中竞价交易 方式减持公司股份不超过650,000股，占公司总股本比例0.22%。 证券代码：300421 证券简称：力星股份 公告编号：2025-018 | 股东名称 | | 任职情况 | 截至本公告日持股数量（股） | 占公司总 ...

江苏力星通用钢球股份有限公司 2024 年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误 导性陈述或重大遗漏。 江苏力星通用钢球股份有限公司（以下简称"公司"或"本公司"）2024 年 度利润分配方案已获 2025 年 5 月 15 日召开的公司 2024 年度股东大会审议通过， 股东大会决议公告已于 2025 年 5 月 16 日刊登在证监会指定创业板信息披露网站 ——巨潮资讯网 http：//www.cninfo.com.cn/。现将分红派息实施事宜公告如下： 一、股东大会审议通过利润分配方案等情况 1、公司 2024 年度股东大会审议通过的 2024 年度利润分配方案为：以公司 现有总股本 294,030,484 股为基数，向全体股东每 10 股派发现金股利人民币 1.20 元（含税），合计派发现金股利人民币 35,283,658.08 元（含税），不送红股， 不进行资本公积金转增股本。 证券代码：300421 证券简称：力星股份 公告编号：2025-017 如公司在实施权益分派的股权登记日前公司总股本发生变动，将按照"现金 分红总额"固定不变的原则对分 ...

的 北京市环球律师事务所上海分所 关于 江苏力星通用钢球股份有限公司 2024 年度股东大会 见证法律意见书 北京市环球律师事务所上海分所 关于江苏力星通用钢球股份有限公司 2024 年度股东大会的见证法律意见书 GLO2025SH（法）字第 0565 号 致：江苏力星通用钢球股份有限公司 北京市环球律师事务所上海分所（以下称"本所"）接受江苏力星通用钢 球股份有限公司（以下称"公司"）的委托，根据《中华人民共和国公司法》（以 下称"《公司法》"）、《中华人民共和国证券法》（以下称"《证券法》"）、中 国证券监督管理委员会（以下称"中国证监会"）发布的《上市公司股东会规则》 （以下称"《股东会规则》"）及《江苏力星通用钢球股份有限公司章程》（以 下称"《公司章程》"）的有关规定，就公司于 2025 年 5 月 15 日召开的 2024 年度股东大会（以下称"本次股东大会"）的有关事宜，出具本法律意见书。 为了出具本法律意见书，本所律师列席了公司本次股东大会并审查了公司提 供的有关公司召开本次股东大会的文件。 本法律意见书仅供公司为本次股东大会之目的而使用，不得被任何人用于其 他任何目的。本所在此同意，可以将本 ...

一、会议召开和出席情况 证券代码：300421 证券简称：力星股份 公告编号：2025-016 江苏力星通用钢球股份有限公司 关于 2024 年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1、会议时间 （1）现场会议时间：2025 年 5 月 15 日下午 1:30； （2）网络投票时间：2025 年 5 月 15 日，其中：①通过深圳证券交易所交 易系统投票的时间为 2025 年 5 月 15 日 9:15-9:25，9:30-11:30 和 13:00-15:00；② 通过深圳证券交易所互联网系统投票的具体时间为：2025 年 5 月 15 日 9:15— 15:00。 （3）会议地点：江苏力星通用钢球股份有限公司三楼贵宾 3 会议室； （4）会议召开方式：本次股东大会采用现场投票与网络投票相结合的方式 召开； （5）会议召集人：公司董事会； （6）会议主持人：董事长施祥贵先生； （7）本次股东大会的召集和召开符合《公司法》《上市公司股东大会规则》 及《公司章程》的有关规定，合法有效。 2、出席情况 1、本次股东大会不存 ...